Inhibition of Cholesterol Synthesis by Green and Black Tea
绿茶和红茶抑制胆固醇合成
基本信息
- 批准号:7701289
- 负责人:
- 金额:$ 18.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:5&apos-AMP-activated protein kinaseAcute DiseaseAdverse effectsAlternative MedicineAnimalsAntibodiesBeveragesBiliaryBiological AssayBlack TeaBloodBotanicalsCellsCholesterolCholesterol Synthesis InhibitionChronicConsumptionCyclic AMP-Dependent Protein KinasesDeacetylaseDiabetes MellitusDoseEnzyme ActivationEnzyme InhibitionEnzymesGreen teaHepaticHydroxymethylglutaryl-CoA reductaseImmunoblottingIntakeKnowledgeLDL Cholesterol LipoproteinsLeadLiverMeasuresMediatingMetabolic syndromeMonitorMusOralPathway interactionsPharmaceutical PreparationsPharmacologic SubstancePhosphorylationPhosphotransferasesPreparationProtein KinaseResearchResveratrolRoleSTK11 geneSerumSignal PathwaySmall Interfering RNASolidSterolsTeaWaterabsorptionadenylate kinasediabetes managementdietary supplementsfunctional foodhepatoma cellhypercholesterolemiain vivointerestknock-downmanpolyphenolupstream kinase
项目摘要
DESCRIPTION (provided by applicant): "Functional foods", herbal and other botanical products, and nutritional supplements have gained great popularity among the public as safe and effective means to treat chronic and acute diseases. As hypercholesterolemia is a widespread problem for which there is great interest in alternative medicines, the demonstrated ability of black tea to decrease serum cholesterol levels is of particular interest. Similarly, green tea has been shown to be hypocholesterolemic in animal studies. The mechanism by which these safe and widely consumed beverages act to lower cholesterol has not yet been elucidated. Although most current evidence indicates that tea polyphenols reduce the absorption of dietary and biliary cholesterol, our recent studies with hepatoma cells indicate that green and black tea extracts also decrease cholesterol synthesis via both direct enzyme inhibition and by suppression of HMG-CoA reductase activity. Knowledge of how tea consumption lowers cholesterol levels is essential to understanding the benefits and potential adverse effects of its intake, particularly in combination with prescription pharmaceuticals, including the statin drugs, which similarly inhibit cholesterol synthesis at HMG-CoA reductase. As our current studies indicate that tea extracts cause the activation of AMP-kinase to suppress HMG-CoA reductase activity, the objectives of this application are to determine if tea extracts directly activate AMP-kinase, or if upstream signaling pathways are involved; and to determine if tea suppresses cholesterol synthesis in vivo. These studies should delineate the intracellular mechanism by which tea compounds suppress cholesterol synthesis, and elucidate the extent to which suppression of cholesterol synthesis contributes to the hypocholesterolemic effect of green and black tea. These studies should establish a solid, mechanistic understanding of how tea decreases cholesterol synthesis and lowers blood cholesterol levels, and, given the developing recognition of the role of AMP-kinase in diabetes, may also open new pathways to the management of diabetes and "metabolic syndrome".
描述(由申请人提供):“功能性食品”、草药和其他植物产品以及营养补充剂作为治疗慢性和急性疾病的安全有效的手段而受到公众的广泛欢迎。由于高胆固醇血症是一个普遍存在的问题,人们对替代药物非常感兴趣,因此红茶降低血清胆固醇水平的能力尤其令人感兴趣。同样,动物研究表明绿茶具有降低胆固醇的作用。这些安全且广泛饮用的饮料降低胆固醇的机制尚未阐明。尽管目前大多数证据表明茶多酚会减少膳食胆固醇和胆汁胆固醇的吸收,但我们最近对肝癌细胞的研究表明,绿茶和红茶提取物还可以通过直接酶抑制和抑制 HMG-CoA 还原酶活性来减少胆固醇合成。了解饮茶如何降低胆固醇水平对于了解饮茶的益处和潜在的副作用至关重要,特别是与处方药(包括他汀类药物)结合使用时,他汀类药物同样会抑制 HMG-CoA 还原酶的胆固醇合成。由于我们目前的研究表明,茶提取物会激活 AMP-激酶,从而抑制 HMG-CoA 还原酶活性,因此本应用的目的是确定茶提取物是否直接激活 AMP-激酶,或者是否涉及上游信号通路;并确定茶是否抑制体内胆固醇合成。这些研究应该阐明茶化合物抑制胆固醇合成的细胞内机制,并阐明抑制胆固醇合成在多大程度上有助于绿茶和红茶的降胆固醇作用。这些研究应该对茶如何减少胆固醇合成和降低血液胆固醇水平建立一个坚实的、机制性的理解,而且,鉴于人们对 AMP 激酶在糖尿病中的作用的认识不断加深,这些研究也可能为糖尿病和“代谢代谢”的管理开辟新的途径。综合症”。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TODD D PORTER其他文献
TODD D PORTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TODD D PORTER', 18)}}的其他基金
Inhibition of Cholesterol Synthesis by Green and Black Tea
绿茶和红茶抑制胆固醇合成
- 批准号:
7883660 - 财政年份:2009
- 资助金额:
$ 18.14万 - 项目类别:
Inhibition of Cholesterol Synthesis by Policosanol
普利醇对胆固醇合成的抑制
- 批准号:
7195943 - 财政年份:2007
- 资助金额:
$ 18.14万 - 项目类别:
Inhibition of Cholesterol Synthesis by Policosanol
普利醇对胆固醇合成的抑制
- 批准号:
7415194 - 财政年份:2007
- 资助金额:
$ 18.14万 - 项目类别:
AMES MUTAGENICITY TESTING WITH RECOMBINANT HUMAN P450S
使用重组人 P450S 进行 AMES 突变性测试
- 批准号:
2155287 - 财政年份:1992
- 资助金额:
$ 18.14万 - 项目类别:
AMES MUTAGENICITY TESTING WITH RECOMBINANT HUMAN P450S
使用重组人 P450S 进行 AMES 突变性测试
- 批准号:
2155288 - 财政年份:1992
- 资助金额:
$ 18.14万 - 项目类别:
AMES MUTAGENICITY TESTING WITH RECOMBINANT HUMAN P-450S
使用重组人 P-450S 进行 AMES 突变性测试
- 批准号:
3254685 - 财政年份:1992
- 资助金额:
$ 18.14万 - 项目类别:
AMES MUTAGENICITY TESTING WITH RECOMBINANT HUMAN P450S
使用重组人 P450S 进行 AMES 突变性测试
- 批准号:
2391600 - 财政年份:1992
- 资助金额:
$ 18.14万 - 项目类别:
相似国自然基金
AMPK通过调控Smurf1的SUMO化抑制创伤性异位骨化的研究
- 批准号:31900852
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
血管微环境中内皮细胞AMPK抑制心肌纤维化的功能与机制研究
- 批准号:81800273
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于AMPK-FXR-BSEP介导的齐墩果酸所致胆汁淤积性肝损伤作用机制研究
- 批准号:81760678
- 批准年份:2017
- 资助金额:35.0 万元
- 项目类别:地区科学基金项目
基于AMPK信号通路研究菝葜黄酮调控脂类代谢分子机制
- 批准号:81760157
- 批准年份:2017
- 资助金额:32.0 万元
- 项目类别:地区科学基金项目
AMPK通过Wnt/β-catenin信号通路调控绵羊肌内脂肪前体细胞分化的研究
- 批准号:31402053
- 批准年份:2014
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Multimodal control of mitochondrial energetics to shape biological aging
线粒体能量的多模式控制塑造生物衰老
- 批准号:
10864185 - 财政年份:2023
- 资助金额:
$ 18.14万 - 项目类别:
Immunometabolic regulation after CNS injury
中枢神经系统损伤后的免疫代谢调节
- 批准号:
10737334 - 财政年份:2023
- 资助金额:
$ 18.14万 - 项目类别:
Exercise and muscle mitochondria in Alzheimer's Disease
阿尔茨海默病中的运动和肌肉线粒体
- 批准号:
10740455 - 财政年份:2023
- 资助金额:
$ 18.14万 - 项目类别:
AMPK Regulation of ACE2 in Endothelial Health and Disease
AMPK 在内皮健康和疾病中对 ACE2 的调节
- 批准号:
10568995 - 财政年份:2022
- 资助金额:
$ 18.14万 - 项目类别: